Institution
Nanjing Medical University
Education•Nanjing, China•
About: Nanjing Medical University is a education organization based out in Nanjing, China. It is known for research contribution in the topics: Cancer & Cell growth. The organization has 52221 authors who have published 37904 publications receiving 635831 citations. The organization is also known as: National Jiangsu Medical College & Nanjing Medical College.
Topics: Cancer, Cell growth, Medicine, Population, Apoptosis
Papers published on a yearly basis
Papers
More filters
••
TL;DR: It is demonstrated that SP1-induced ZFAS1 contributed to CRC progression by upregulating VEG FA via competitively binding to miR-150-5p, which acts as a tumor suppressor by targeting VEGFA in CRC.
Abstract: Increasing long non-coding RNAs (lncRNAs) have been reported to play key roles in the development and progression of various malignancies ZNFX1 antisense RNA1 (ZFAS1) has been reported to be aberrant expression and suggested as a tumor suppressor or oncogene in many cancers However, the biological role and underlying molecular mechanism of ZFAS1, especially the miRNA sponge role of which in CRC remain largely unknown We found that ZFAS1 expression was higher in CRC tissues, where it was associated with poor overall survival (OS), we also showed that ZFAS1 upregulation was induced by nuclear transcription factor SP1 Moreover, ZFAS1 and VEGFA are both targets of miR-150-5p, while ZFAS1 binds to miR-150-5p in an AGO2-dependent manner Additionally, ZFAS1 upregulation markedly promoted as well as ZFAS1 knockdown significantly suppressed CRC cell proliferation, migration, invasion and angiogenesis, and the inhibitory effect caused by ZFAS1 knockdown could be reversed by antagomiR-150-5p Lastly, we demonstrated that ZFAS1 knockdown inhibited EMT process and inactivated VEGFA/VEGFR2 and downstream Akt/mTOR signaling pathway in CRC Our data demonstrated that SP1-induced ZFAS1 contributed to CRC progression by upregulating VEGFA via competitively binding to miR-150-5p, which acts as a tumor suppressor by targeting VEGFA in CRC
160 citations
••
TL;DR: This work aims to provide a systematic literature review of the determinants of cancer research in China and its applications in the field of Digestive Diseases and Dermatology and Venereology.
Abstract: Lijuan Sun, Lanjing Ma, Yubo Ma, Faming Zhang, Changhai Zhao, Yongzhan Nie 1 State Key Laboratory of Cancer Biology & Institute of Digestive Diseases Xijing Hospital, The Fourth Military Medical University, Xi’an 710032, China 2 Department of Clinical Nutrition, Xi Jing Hospital, The Fourth Military Medical University, Xi’an 710032, China 3 Department of Dermatology and Venereology, Peking University First Hospital, Research Center for Medical Mycology, Peking University, Beijing 100034, China 4 Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210001, China & Correspondence: yongznie@fmmu.edu.cn (Y. Nie)
160 citations
••
TL;DR: Proteomic technology was used to compare sperm protein expression profiles in asthenozoospermic patients with that of normozoosPermic donors and 10 differentially expressed proteins were identified.
159 citations
••
TL;DR: It is concluded that MSCs in patient with SLE have abnormalities compared with those in normal control, and may play an important role in the SLE pathogenesis.
Abstract: Bone marrow-derived mesenchymal stem cells (MSCs) are key components of the hematopoietic microenvironment and provide support to hematopoiesis and modulate immune system. Several studies suggest that SLE may be seen as stem cell disorders. However, it is unclear that whether MSCs from SLE patients are defective. So in this research, we studied the biological character of bone marrow derived MSCs in patients with SLE, focused on their phenotype (morphology and immunophenotype), karyotype, cytokines expression and hematopoietic support of MSCs. Our results showed that MSCs from SLE patients and normal controls can be successfully culture-expanded, but the MSCs from SLE grew more slowly than those of normal controls (P < 0.05). Cells from both groups were positive for CD29, CD44 and CD105, and negative for CD14, CD34, CD45 and HLA-DR. MSCs from SLE have a normal karyotype. Both groups express IL-6, IL7, IL-11, macrophage colony stimulating factor (M-CSF) and stem cell factor (SCF) at mRNA level. While IL-6 and IL-7 were down-regulated in MSCs from SLE patient (P < 0.05) at mRNA level. The MSCs from SLE patients and normal controls were infused into ICR (Tac: Icr: Ha strain) mice after high-dose chemotherapy, with no adverse events in either group. Recovery of white blood cells, hemoglobin and platelet was more rapid (P < 0.05) compared with the group without MSCs infusion. We conclude that MSCs in patient with SLE have abnormalities compared with those in normal control. MSCs in patient with SLE may play an important role in the SLE pathogenesis.
159 citations
••
TL;DR: OSA is independently associated with subsequent MACCEs in patients undergoing percutaneous coronary intervention and Evaluation of therapeutic approaches to mitigate OSA-associated risk is warranted.
Abstract: Background—There is a paucity of data from large cohort studies examining the prognostic significance of obstructive sleep apnea (OSA) in patients with coronary artery disease. We hypothesized that...
159 citations
Authors
Showing all 52549 results
Name | H-index | Papers | Citations |
---|---|---|---|
Yi Chen | 217 | 4342 | 293080 |
H. S. Chen | 179 | 2401 | 178529 |
Feng Zhang | 172 | 1278 | 181865 |
Yang Yang | 171 | 2644 | 153049 |
Lei Jiang | 170 | 2244 | 135205 |
Peter T. Fox | 131 | 622 | 83369 |
Peter J. Anderson | 120 | 966 | 63635 |
Jinde Cao | 117 | 1430 | 57881 |
John P. Neoptolemos | 112 | 648 | 52928 |
Wei Zhang | 112 | 1189 | 93641 |
Jie Wu | 112 | 1537 | 56708 |
Jinhua Ye | 112 | 658 | 49496 |
Patrick Y. Wen | 109 | 838 | 52845 |
Fei Wang | 107 | 1824 | 53587 |
David C. Christiani | 100 | 1052 | 55399 |